Adam Stern

Director/Board Member chez ORGANOVO HOLDINGS, INC. Fortune : 525 783 $ au 31/03/2024

Profil

Adam K.
Stern is currently the Chief Executive Officer & Partner at SternAegis Ventures LLC, Independent Director at Organovo Holdings, Inc., Director at DarioHealth Corp., and Director at Aerami Therapeutics Holdings, Inc. He previously held positions such as Senior Managing Director at Augment Securities, Inc., Director at Organovo Holdings, Inc., Director at InVivo Therapeutics Corp., and Director at Matinas BioPharma Holdings, Inc. He also served as SVP & Managing Director-Private Equity Marketing at Josephthal & Co (Broker).
Stern received his undergraduate degree from the University of South Florida in 1987.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
DARIOHEALTH CORP. 1,17%	06/03/2024	317 250 ( 1,17% )	485 393 $	31/03/2024
ORGANOVO HOLDINGS, INC. 0,39%	17/11/2023	39 214 ( 0,39% )	40 390 $	31/03/2024

Postes actifs de Adam Stern

Sociétés	Poste	Début
DARIOHEALTH CORP.	Director/Board Member	01/03/2020
ORGANOVO HOLDINGS, INC.	Director/Board Member	14/07/2020
Aerami Therapeutics Holdings, Inc.	Director/Board Member	-
Aerami Therapeutics, Inc.	Director/Board Member	01/12/2014
SternAegis Ventures LLC	Chief Executive Officer	01/11/2012

Anciens postes connus de Adam Stern

Sociétés	Poste	Fin
WESTERN ACQUISITION VENTURES CORP.	Director/Board Member	28/12/2023
MATINAS BIOPHARMA HOLDINGS, INC.	Director/Board Member	02/11/2020
HYDROFARM HOLDINGS GROUP, INC.	Director/Board Member	01/01/2020
DARIOHEALTH CORP.	Director/Board Member	03/05/2014
░░░░░░░░ ░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

Formation de Adam Stern

University of South Florida

Undergraduate Degree